{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:01:22Z","timestamp":1784563282416,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009054","name":"International Centre for Diarrhoeal Disease Research, Bangladesh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bangladesh has an intermediate endemicity of hepatitis B virus (HBV), with prevalence exceeding the global average. In border areas like Teknaf, where more than a million Forcibly Displaced Myanmar Nationals (FDMNs), as well as the Local Community Bangladeshi Nationals (host community), may be at increased risk of HBV and hepatitis C virus (HCV). We aimed to explore the knowledge, attitudes, and practices (KAP) regarding HBV and HCV in these populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a cross-sectional study among adults who reported to the Severe Acute Respiratory Infection (SARI) Hospital in Teknaf, Cox\u2019s Bazar, between April 2021 and March 2022. A structured questionnaire was developed to assess the participants\u2019 knowledge, attitudes, and practices on HBV or HCV. Simultaneously, blood specimens from the participants were analysed to explore their infection status. KAP scores were calculated by assigning one point for each correct response, and participants were classified as satisfactory or unsatisfactory based on a midpoint cut-off of the total possible score. A p-value of &lt;\u20090.05 was considered significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 654 participants were enrolled; 58 (8.86%) were FDMNs and 596 (91.14%) were host community. Overall, 23 (3.52%) tested positive for either HBV or HCV, including 11 (18.97%) FDMNs and 12 (2.01%) host community (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). HBV positivity was comparable between FDMNs and host community (1.72% vs. 1.01%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.480). HCV positivity was higher among FDMNs than host community (17.24% vs. 1.01%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Satisfactory knowledge was observed in 5.17% of FDMNs and 12.25% of host community; satisfactory attitude in 71.70% and 81.12%, respectively; and satisfactory practice in 37.93% and 50.00%. FDMNs had poorer awareness of HBV vaccination (0.00% vs. 9.73%) and vertical transmission (6.90% vs. 19.33%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>KAP regarding HBV and HCV was low in both populations, particularly among FDMNs, who also had a substantially higher infection burden. Targeted health education, culturally appropriate awareness programmes, and improved access to screening and care may help reduce future viral hepatitis transmission in both communities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-026-27880-6","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T05:03:53Z","timestamp":1779685433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The hidden burden of viral hepatitis: a comparative study of KAP and infections among rohingya refugees and host communities in Bangladesh"],"prefix":"10.1186","volume":"26","author":[{"given":"Shoeb Bin","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6695-6342","authenticated-orcid":false,"given":"Md Fuad","family":"Al Fidah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvir Ahmed","family":"Rasel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharika","family":"Nuzhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monira","family":"Sarmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammod Jobayer","family":"Chisti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahmeed","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Munirul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"27880_CR1","unstructured":"Organization WH. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021: accountability for the global health sector strategies 2016\u20132021: actions for impact. 2021."},{"issue":"1","key":"27880_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cld.1197","volume":"19","author":"M Ali","year":"2022","unstructured":"Ali M, Rahman MA, Njuguna H, Rahman S, Hossain R, Sayeed A, Ahmed F, Alam S, Azam G, Safwath SA. High Prevalence of Hepatitis B and C virus infections among rohingya refugees in Bangladesh: a growing Concern for the refugees and the Host Communities. Clin Liver Disease. 2022;19(1):1.","journal-title":"Clin Liver Disease"},{"issue":"1","key":"27880_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5005\/jp-journals-10018-1297","volume":"9","author":"M Al Mahtab","year":"2019","unstructured":"Al Mahtab M, Akbar SMF, Takahashi K, Adnan ABM, Alam MA, Noor-E-Alam SM, Mohsena M, Mahtab M, Uddin MH, Kaisar SG. Alarming levels of hepatitis C virus prevalence among rohingya refugees in Bangladesh: emergency national and international actions warranted. Euroasian J Hepato-Gastroenterology. 2019;9(1):55.","journal-title":"Euroasian J Hepato-Gastroenterology"},{"issue":"12","key":"27880_CR4","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","volume":"30","author":"J Ott","year":"2012","unstructured":"Ott J, Stevens G, Groeger J, Wiersma S. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212\u20139.","journal-title":"Vaccine"},{"key":"27880_CR5","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1017\/S0950268822000061","volume":"150","author":"S Banik","year":"2022","unstructured":"Banik S, Datta A, Ghosh A, Ghosh KY, Debi H. The prevalence of hepatitis B virus infection in Bangladesh: a systematic review and meta-analysis. Epidemiol Infect. 2022;150:e47.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"27880_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3329\/bsmmuj.v2i1.3705","volume":"2","author":"M Al-Mahtab","year":"2009","unstructured":"Al-Mahtab M, Rahman S, Karim F, Foster G, Solaiman S. Epidemiology of hepatitis C virus in Bangladeshi general population. Bangabandhu Sheikh Mujib Med Univ J. 2009;2(1):14\u20137.","journal-title":"Bangabandhu Sheikh Mujib Med Univ J"},{"issue":"7","key":"27880_CR7","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S2468-1253(25)00094-9","volume":"10","author":"B Schramm","year":"2025","unstructured":"Schramm B, Ashakin KA, Firuz W, Hadiuzzaman M, Ben-Farhat J, Arias-Rodriguez A, Rahman A, Gupta PS, Bhuiyan A, Duka M, et al. Prevalence of hepatitis C virus seropositivity and active infection in a Rohingya refugee population in Cox\u2019s Bazar camps, Bangladesh: a cross-sectional study. Lancet Gastroenterol Hepatol. 2025;10(7):648\u201357.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"27880_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-13-50","volume":"13","author":"W Baha","year":"2013","unstructured":"Baha W, Foullous A, Dersi N, They-they TP, Nourichafi N, Oukkache B, Lazar F, Benjelloun S, Ennaji MM, Elmalki A. Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco. BMC Public Health. 2013;13(1):1\u20138.","journal-title":"BMC Public Health"},{"issue":"4","key":"27880_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0749-3797(01)00292-6","volume":"20","author":"G Rischitelli","year":"2001","unstructured":"Rischitelli G, Harris J, McCauley L, Gershon R, Guidotti T. The risk of acquiring hepatitis B or C among public safety workers: a systematic review. Am J Prev Med. 2001;20(4):299\u2013306.","journal-title":"Am J Prev Med"},{"issue":"1","key":"27880_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-015-1476-0","volume":"15","author":"JA Owiti","year":"2015","unstructured":"Owiti JA, Greenhalgh T, Sweeney L, Foster GR, Bhui KS. Illness perceptions and explanatory models of viral hepatitis B & C among immigrants and refugees: a narrative systematic review. BMC Public Health. 2015;15(1):1\u201317.","journal-title":"BMC Public Health"},{"key":"27880_CR11","unstructured":"Goutille F, Crini V, Jullien P. Knowledge, attitudes and practices for risk education [Multim\u00e9dia multisupport]: how to implement KAP surveys: guideline for KAP survey manager. In.; 2009."},{"issue":"1","key":"27880_CR12","first-page":"7","volume":"4","author":"K Kaliyaperumal","year":"2004","unstructured":"Kaliyaperumal K. Guideline for conducting a knowledge, attitude and practice (KAP) study. AECS illumination. 2004;4(1):7\u20139.","journal-title":"AECS illumination"},{"key":"27880_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-13-448","volume":"13","author":"N ul Haq","year":"2013","unstructured":"ul Haq N, Hassali MA, Shafie AA, Saleem F, Farooqui M, Haseeb A, Aljadhey H. A cross-sectional assessment of knowledge, attitude and practice among Hepatitis-B patients in Quetta, Pakistan. BMC Public Health. 2013;13:1\u20139.","journal-title":"BMC Public Health"},{"key":"27880_CR14","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1186\/1471-2458-12-692","volume":"12","author":"N ul Haq","year":"2012","unstructured":"ul Haq N, Hassali MA, Shafie AA, Saleem F, Farooqui M, Aljadhey H. A cross sectional assessment of knowledge, attitude and practice towards Hepatitis B among healthy population of Quetta, Pakistan. BMC Public Health. 2012;12:692.","journal-title":"BMC Public Health"},{"key":"27880_CR15","unstructured":"Alam M, Tariq WU. Knowledge attitudes and practices about Hepatitis B and C among young healthy males. Pakistan J Pathol 2006, 17."},{"issue":"1","key":"27880_CR16","doi-asserted-by":"publisher","first-page":"e003299","DOI":"10.1136\/bmjpo-2024-003299","volume":"9","author":"S Nuzhat","year":"2025","unstructured":"Nuzhat S, Islam MR, Al Fidah MF, Islam SB, Rahman MM, Paul S, Nesa M-U, Chowdhury D, Nabi SF, Awn AMSA. Maternal knowledge, attitude and practice regarding commercial oral rehydration salt solution: experience from a diarrhoeal disease hospital in Bangladesh. BMJ Paediatrics Open. 2025;9(1):e003299.","journal-title":"BMJ Paediatrics Open"},{"issue":"3","key":"27880_CR17","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1016\/S2542-5196(19)30041-5","volume":"3","author":"D Devakumar","year":"2019","unstructured":"Devakumar D, Garry S, Birch M. Violence and mortality in Rohingya migrants from the Northern Rakhine State, Myanmar. Lancet Planet Health. 2019;3(3):e107\u20138.","journal-title":"Lancet Planet Health"},{"issue":"8","key":"27880_CR18","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.vaccine.2018.01.025","volume":"36","author":"L Wilson","year":"2018","unstructured":"Wilson L, Rubens-Augustson T, Murphy M, Jardine C, Crowcroft N, Hui C, Wilson K. Barriers to immunization among newcomers: a systematic review. Vaccine. 2018;36(8):1055\u201362.","journal-title":"Vaccine"},{"key":"27880_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.puhe.2016.04.003","volume":"138","author":"H Budhwani","year":"2016","unstructured":"Budhwani H, De P. Disparities in influenza vaccination across the United States: Variability by minority group, Asian sub-populations, socio-economic status, and health insurance coverage. Public Health. 2016;138:146\u201353.","journal-title":"Public Health"},{"key":"27880_CR20","volume-title":"Global health sector strategy on viral hepatitis 2016\u20132021","author":"WHO","year":"2016","unstructured":"WHO. Towards ending viral hepatitis. Global health sector strategy on viral hepatitis 2016\u20132021. In.: World Health Organization; 2016."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-27880-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27880-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27880-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:01:45Z","timestamp":1784559705000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-27880-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["27880"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-27880-6","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research protocol was reviewed and approved by the Institutional Review Board (IRB) of icddr, b, comprising the Research Review Committee (RRC) and the Ethics Review Committee (ERC) (Protocol No. PR-21222, Version 2.0; approved on 25 February 2021). The study was conducted in accordance with the principles of the Declaration of Helsinki and relevant national regulations governing research involving human participants. All clinical procedures were monitored by researchers and trained physicians to ensure adherence to ethical and scientific standards. Prior to data analysis, all participant identifiers were removed to maintain confidentiality.Written informed consent was obtained from all participants following full disclosure of the study objectives, procedures, potential risks, and benefits. Participation was entirely voluntary, and participants were informed of their right to withdraw from the study at any stage without any adverse consequences. Participants who agreed to participate either signed the consent form or provided a thumb impression. No relevant information was withheld from the participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"2174"}}